Male Lichen Sclerosus - Risk Factors, Treatment, and Impact on Quality of Life
ConditionLichen Sclerosus
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18+
SponsorRegion Västerbotten
About this trial
This observational study aims to evaluate routine treatment outcomes in men with lichen sclerosus (LS), including a long-term follow-up to assess disease progression and histopathological changes. The study also investigates potential risk factors for LS and the disease's impact on quality of life and sexual health.
Eligibility criteria
Qualifiers
Biologically male
≥18 years old
Referred to the dermatology department or the urology department in Västerbotten and diagnosed with LS.
Must be able to read and write Swedish to fill in questionnaire and informed consent.
Disqualifiers
Age under 18 years old
Not able to read and write in Swedish.
Unable to leave an informed consent to participate.
Trial design
Treatments tested in this trial
- Circumcision
Treatment groups
300 Participants
are divided into 4 treatment groupsSponsors and collaborators
Region Västerbotten
Lead sponsor
Umeå University
Collaborator
Source ClinicalTrials.gov